uniQure: Now What?
Source: SeekingAlpha
2026-01-08 15:36:35 ET
Overview
In my last uniQure ( QURE ) write-up , the company was preparing to launch AMT-130, a gene therapy, for Huntington’s disease, or HD....
Read the full article on Seeking Alpha
For further details see:
uniQure: Now What?
uniQure N.V.
NASDAQ: QURE
QURE Trading
-13.46% G/L:
$15.17 Last:
1,399,279 Volume:
$16.83 Open:
QURE Latest News
QURE Stock Data
$1,555,111,367
59,307,892
N/A
61
N/A
Biotechnology & Life Sciences
Healthcare
NL
Amsterdam
